New research shows that a widely available antidepressant could be even more effective than a new pill from Merck at treating Covid-19. And it's much less expensive. Speaking of that pill, Merck will allow a nonprofit group to manufacture it for low and middle income countries. But it won't allow for a generic option. The FDA is expected to give final approval to Pfizer's vaccine for 5 to 11 year old kids later this week. How much resistance will we see from parents? Yet another thing made worse by the pandemic: Childhood obesity. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices